Insomnia drug can improve brain function

A new study reported that zolpidem, a drug normally used to treat insomnia, temporarily improved brain function in a patient suffering from akinetic mutism, a condition in which the person is alert but cannot speak or move. The patient was able to communicate, walk, and eat without assistance after receiving the drug for a bout of insomnia. The study was published in the March 2007 issue of Annals of Neurology, the official journal of the American Neurological Association.

Led by Christine Brefel-Courbon, M.D., of the University Hospital in Toulouse, France, researchers conducted a study of a 48 year-old woman who developed akinetic mutism due to oxygen deprivation to her brain following an attempted suicide by hanging. The patient was totally dependent, unable to speak or walk, and was using a feeding tube for nourishment, although she was able to understand single words. Two years after the suicide attempt, she was given zolpidem for a bout of insomnia; 20 minutes later, she was able to communicate to her family, eat by herself, and move. These effects lasted for up to three hours. After systematically withdrawing all of her medications one by one, it was concluded that the positive effect was due to zolpidem. "This phenomenon was so reproducible that caregivers used to give her up to three tablets each day without sleepiness as 'side effect,'" the authors state.

The researchers systematically assessed the effect of zolpidem on motor and cognitive function and explored its effect on brain activity using positron emission tomography (PET) scans. They administered motor tests such as finger tapping and walking, and language tests such as spontaneous speech, word repetition, and object naming. They also conducted brain imaging studies to assess brain metabolism and cognitive activation using PET scans. All of these were conducted with both zolpidem and a placebo in a randomized, double-blind study.

The results showed that after receiving zolpidem, the patient was able to stand up and walk, repeat words and sentences, read words, and name objects, although she was not able to speak spontaneously. Administration of the drug increased brain metabolism, and PET scans also showed improvement in cerebral areas involved in motivational processing.

Although previous studies have shown the positive effect of zolpidem on catatonic conditions, the authors state, "To our knowledge, this is the first study assessing the impact of zolpidem of post-anoxic brain injury using the modern methodological standards of clinical pharmacology." The authors demonstrated increased brain activity in the frontal cortex, which is associated with higher cognitive performances, with zolpidem. They suggest that the mechanism may be due to an activation of neural circuits in the brain that control movement and verbal expression, but that the lesions that occurred due to oxygen deprivation may have been too severe to allow spontaneous speech. They conclude that single patient trials can be a logical approach to identifying potentially beneficial drugs, especially in the case of rare or orphan diseases.

Source: John Wiley & Sons, Inc.

Related stories:

Sleeping drug breaks man's 3-year coma
A 28-year-old South African man who has been comatose since an accident three years ago is able to wake up with the unlikely help of a sleeping medication.
Scientists restore movement to paralyzed limbs through artificial brain-muscle connections
Researchers in a study funded by the National Institutes of Health have demonstrated for the first time that a direct artificial connection from the brain to muscles can restore voluntary movement in monkeys whose arms have been temporarily anesthetized. The results may have promising implications for the quarter of a million Americans affected by spinal cord injuries and thousands of others with paralyzing neurological diseases, although clinical applications are years away.
Brain-nourishing molecule may predict schizophrenia relapse
A factor that helps optimize brain formation and function may also provide clues about whether patients suffering with schizophrenia are headed toward relapse, researchers say.
People with autism make more rational decisions, study shows
People with autism-related disorders are less likely to make irrational decisions, and are less influenced by gut instincts, according to research funded by the Wellcome Trust. The study adds to the growing body of research implicating altered emotional processing in autism.
Importance of sex-specific testing shown in anxiety study
An Australian study has flagged an important truth for the medical research community. Like their human counterparts, male and female mice are not only different, their respective genetic responses can often be the reverse of what you'd expect from pharmacological results. This has important ramifications for laboratory and clinical testing.
Blindsight: How brain sees what you do not see
Blindsight is a phenomenon in which patients with damage in the primary visual cortex of the brain can tell where an object is although they claim they cannot see it. A research team led by Prof. Tadashi Isa and Dr. Masatoshi Yoshida of the National Institute for Physiological Sciences, Japan, provides compelling evidence that blindsight occurs because visual information is conveyed bypassing the primary visual cortex. Japan Science and Technology Agency supported this study. The team reports their finding in the Journal of Neuroscience on Oct 15, 2008.
Gorilla study gives clues to human language development
(PhysOrg.com) -- A new University of Sussex study provides evidence that gorilla communication is linked to the left hemisphere of the brain - just as it is in humans.
Researchers Use Nanowires to Develop Neural Probe That Will Limit Damage to Cells and Biological Tissue
(PhysOrg.com) -- Engineering researchers at the University of Arkansas have developed a neural probe that demonstrates significantly greater electrical charge storage capacity than all other neural prosthetic devices. More charge storage capacity means the device can stimulate nerves and tissues with less damage and sense neural signals with better sensitivity.

News discussion:

Medicine & Health news